| Arkansas City Presbyterian Manor | |
| 1711 N 4th Street, Arkansas City, Kansas 67005 | |
| (620) 442-8700 | |
| Name | Arkansas City Presbyterian Manor |
|---|---|
| Location | 1711 N 4th Street, Arkansas City, Kansas |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 52.67% |
| Medicare ID (CCN) | 175309 |
| Legal Business Name | Presbyterian Manors Inc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1952404303 |
| Organization Name | PRESBYTERIAN MANORS, INC. |
| Doing Business As | ARKANSAS CITY PRESBYTERIAN MANOR |
| Address | 1711 N 4th St, Arkansas City, KS 67005 |
| Phone Number | 620-442-8700 |
News Archive
Two new faculty members have joined the UNC Lineberger Comprehensive Cancer Center to help launch groundbreaking immunotherapy clinical trials testing an experimental treatment in which patients' own immune cells are genetically engineered to fight their cancer.
A drug used to treat epilepsy has been found to significantly improve tremors, motor fluctuations, and other involuntary movements, or dyskinesias, in patients with Parkinson disease, according to a study published in Neurology, the scientific journal of the American Academy of Neurology.
ProJect Pharmaceutics started business operations and opened its laboratory facilities in the Biotech-cluster in Martinsried, near Munich. ProJect Pharmaceutics transforms proteins, peptides and delicate small molecules into pioneering drugs.
The Harper Government today announced an important investment that will help Canadians in getting more effective treatments and make the healthcare system more sustainable through personalized medicine.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Two new faculty members have joined the UNC Lineberger Comprehensive Cancer Center to help launch groundbreaking immunotherapy clinical trials testing an experimental treatment in which patients' own immune cells are genetically engineered to fight their cancer.
A drug used to treat epilepsy has been found to significantly improve tremors, motor fluctuations, and other involuntary movements, or dyskinesias, in patients with Parkinson disease, according to a study published in Neurology, the scientific journal of the American Academy of Neurology.
ProJect Pharmaceutics started business operations and opened its laboratory facilities in the Biotech-cluster in Martinsried, near Munich. ProJect Pharmaceutics transforms proteins, peptides and delicate small molecules into pioneering drugs.
The Harper Government today announced an important investment that will help Canadians in getting more effective treatments and make the healthcare system more sustainable through personalized medicine.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16.91 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.93 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 68.33 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.76 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 11.29 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.65 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 7.59 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.99 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 93.68 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 3.08 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 18.58 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 12.14 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.81 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |